Nephrology Drugs Market to Witness Robust Growth Supported by Rising Disease Prevalence

 

The global nephrology drugs market is estimated to be valued at US$ 26.9 billion in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031.

Nephrology drugs are used in the treatment of kidney-related diseases including acute kidney injury, chronic kidney disease, kidney stone disease, urinary tract infections and renal diseases among others. The rising incidence and prevalence of kidney disorders such as chronic kidney disease (CKD), chronic glomerulonephritis and polycystic kidney disease have increased the demand for different types of nephrology drugs. With the advancement in healthcare infrastructure and treatment options, the nephrology drugs market is poised to continue its strong growth over the next few years.

Key Takeaways

Key players operating in the nephrology drugs market are Amgen Inc., F. Hoffmann-La Roche Ltd, Sanofi, Novartis AG, AstraZeneca, Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, AbbVie Inc., Genzyme Corporation, Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Shire Pharmaceuticals Limited, Keryx Biopharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd. These players are focusing on new launches and approvals of nephrology drugs for different indications.

Some of the major opportunities in the Nephrology Drugs Market Demand include success in the research and development of novel drugs targeted for orphan kidney diseases and increasing funding for research in nephrology. Global expansion strategies adopted by major players including acquisitions, collaborations, licensing agreements, new product launches and geographical expansions are further fueling the market growth.

Market Drivers and Restraints

Increasing geriatric population worldwide that is more susceptible to develop kidney diseases is a major market driver. Elderly people have higher risks of chronic diseases like diabetes and hypertension - both of which can damage kidneys over time. Aging populations in regions like North America, Europe and Asia Pacific thus present lucrative opportunities.

However, strict regulatory policies for approval of nephrology drugs acts as a market restraint. Since kidney diseases directly impact critical body functions, regulatory authorities closely monitor product development processes and approve drugs only after clinical trials prove safety and efficacy. This significantly increases costs and timelines for companies in this market.

Segment Analysis:

The nephrology drugs market is segmented based on therapeutics, application, and end users. Based on therapeutics, the immunosuppressant segment dominates the market since solid organ transplant procedures such as kidney transplant requires immunosuppressive drugs for life. These drugs prevent the body’s immune system from attacking and rejecting the transplanted organ. Nephrology drugs that are used to treat chronic kidney diseases like chronic glomerulonephritis, chronic kidney failure, and polycystic kidney disease also hold a major share of the market.

Global Analysis:

Regionally, North America holds the major share in Nephrology Drugs Market Regional Analysis and is expected to continue dominating during the forecast period. Factors such as growing incidence of kidney diseases, developed healthcare infrastructure, availability of advanced treatment options, and high healthcare spending contribute to its large share. However, Asia Pacific is poised to grow at the fastest rate due to increasing investment in healthcare sectors by governments, rising medical tourism, growing incidence of lifestyle-related kidney diseases, and improving access to healthcare in emerging economies. Multiple initiatives taken by governments and private organizations to spread awareness about kidney diseases are also boosting the regional market.

Get More Insights on- Nephrology Drugs Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

Comments

Post a Comment

Popular posts from this blog

Plasma Fractionation: The Process of Separating Blood Plasma into Useful Components

Image
  Plasma Fractionation What is Plasma Fractionation? Plasma fraction is the process of separating the different components of blood plasma through various physico-chemical processes like molecular size filtration, precipitation, chromatography and crystallization. Blood plasma, the liquid part of blood, contains thousands of proteins, antibodies, clotting factors and other components which help maintain homeostasis in the body. Plasma Fraction enables isolation of specific plasma proteins on a large scale which are then used to manufacture life-saving plasma derived medicines, diagnostics and medical therapies. Methods used in Plasma Fractionation Several specialized techniques are employed for separating the individual components from pooled donor plasma with high precision and purity. These include: - Cryoprecipitation: Based on temperature-dependent solubility, this involves cooling plasma gradually until certain proteins like Plasma Fractionation precipitate out. The su...
Read more

Theranostics: Transforming the Landscape of Personalized Medicine Innovative Approaches and Groundbreaking Advancements

Image
  Theranostics What is Theranostics? Theragnostics refers to an emerging field in medicine that combines therapeutic and diagnostic capabilities into single agents or platforms. The goal of theragnostics is to provide personalized patient care by selecting appropriate targeted therapies and monitoring their effectiveness. This novel approach has the potential to significantly improve treatment outcomes for many illnesses by matching therapies to individual molecular profiles. Theranostic Agents and Theranostics Theranostics relies on the development of agents and technologies that can both detect specific molecular abnormalities and targets within the body as well as deliver targeted therapies to those same areas. Some examples of theranostic platforms currently under investigation include: - Theranostic Nanoparticles: Nanoparticles are being engineered to incorporate both diagnostic imaging agents like fluorophores as well as targeted drug payloads. These "smart particles...
Read more

Mometasone Furoate Market is Anticipated to Witness High Growth Owing to Growing Prevalence of Allergic Diseases

Image
Mometasone Furoate Market Size Mometasone furoate is a synthetic corticosteroid applied topically to treat conditions such as eczema, psoriasis and dermatitis. It works by reducing inflammation and itching of the skin. It comes as a cream or ointment applied to the skin. Mometasone furoate products are used to treat flare-ups and reduce symptoms of allergic skin conditions. Growing prevalence of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis across the world has increased the demand for anti-allergic medications including mometasone furoate products. The Global mometasone furoate market is estimated to be valued at US$ 1467.01 Bn in 2024 and is expected to exhibit a CAGR of 22.% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the mometasone furoate market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Lonza Group, Miltenyi Biotec, Takara Bio Group, CellGenix GmbH, FUJIFILM Irvine Scientific, Agilent Technol...
Read more